Letter: telaprevir triple therapy in chronic hepatitis C genotype 1 patients receiving haemodialysis

被引：16
|
作者：
Wiegand, J. [1 ]
Maasoumy, B. [2 ]
Buggisch, P. [3 ]
Buslau, A. [4 ]
Schiefke, I. [5 ]
Berg, T. [1 ]
Wedemeyer, H.
Sarrazin, C. [4 ]
Hinrichsen, H. [6 ]
机构：
[1] Univ Klinikum Leipzig, Klin Gastroenterol & Rheumatol, Leipzig, Germany
[2] Hannover Med Sch, Abt Gastroenterol Hepatol & Endokrinol, D-30623 Hannover, Germany
[3] Inst Interdisziplinare Med Hamburg, Hamburg, Germany
[4] Univ Frankfurt Klinikum, Med Klin 1, Frankfurt, Germany
[5] Krankenhaus St Georg Leipzig, Klin Gastroenterol & Hepatol, Leipzig, Germany
[6] Gastroenterol Hepatol Zentrum Kiel, Kiel, Germany
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 39卷 / 11期
关键词：
BUDD-CHIARI-SYNDROME; MANAGEMENT; TIPS;
D O I：
10.1111/apt.12748
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1342 / 1344
页数：3
相关论文
共 50 条
  • [41] Safety of triple therapy with Telaprevir hemophiliacs with hepatitis C
    Ioannidou, Panagiota
    Kouramba, Anna
    Adraktas, Theophanis
    Mandraki, Maria
    Olga, Katsarou
    HAEMOPHILIA, 2014, 20 : 39 - 40
  • [42] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir Reply
    Gordon, Stuart C.
    Yee, Leland J.
    Martins, Eduardo Bruno
    HEPATOLOGY, 2014, 59 (06) : 2427 - 2427
  • [43] Efficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection
    Cunningham, Morven
    Foster, Graham R.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (02) : 139 - 151
  • [44] Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1
    Akuta, Norio
    Suzuki, Fumitaka
    Fukushima, Taito
    Kawamura, Yusuke
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Hara, Tasuku
    Kobayashi, Mariko
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumadaa, Hiromitsu
    JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (09) : 2862 - 2868
  • [45] Telaprevir A Review of its Use in the Management of Genotype 1 Chronic Hepatitis C
    Perry, Caroline M.
    DRUGS, 2012, 72 (05) : 619 - 641
  • [46] Relationship between HCV dynamics and sustained virological responses in chronic hepatitis C genotype 1b patients treated with telaprevir-based triple therapy
    Nakagawa, Ai
    Atsukawa, Masanori
    Tsubota, Akihito
    Shimada, Noritomo
    Abe, Hiroshi
    Kondo, Chisa
    Itokawa, Norio
    Arai, Taeang
    Hashimoto, Satomi
    Matsushita, Yoko
    Fukuda, Takeshi
    Nakatsuka, Katsuhisa
    Iwakiri, Katsuhiko
    Kawamoto, Chiaki
    Aizawa, Yoshio
    Sakamoto, Choitsu
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (12) : 1329 - 1334
  • [47] Triple therapy with telaprevir: results in hepatitis C virus-genotype 1 infected relapsers and non-responders
    Forestier, Nicole
    Zeuzem, Stefan
    LIVER INTERNATIONAL, 2012, 32 : 44 - 50
  • [48] Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naive Genotype 1b Chronic Hepatitis C Patients
    Abe, Hiroshi
    Tsubota, Akihito
    Shimada, Noritomo
    Atsukawa, Masanori
    Kato, Keizo
    Takaguchi, Koichi
    Asano, Toru
    Chuganji, Yoshimichi
    Sakamoto, Choitsu
    Toyoda, Hidenori
    Kumada, Takashi
    Ide, Tatsuya
    Sata, Michio
    Aizawa, Yoshio
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [49] Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection
    Ogawa, Eiichi
    Furusyo, Norihiro
    Kajiwara, Eiji
    Nomura, Hideyuki
    Kawano, Akira
    Takahashi, Kazuhiro
    Dohmen, Kazufumi
    Satoh, Takeaki
    Azuma, Koichi
    Nakamuta, Makoto
    Koyanagi, Toshimasa
    Kotoh, Kazuhiro
    Shimoda, Shinji
    Hayashi, Jun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (12) : 1759 - 1767
  • [50] A Small Percentage of Patients With Hepatitis C Receive Triple Therapy With Boceprevir or Telaprevir
    Chen, Emerson Y.
    Sclair, Seth N.
    Czul, Frank
    Apica, Betty
    Dubin, Perry
    Martin, Paul
    Lee, William M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (08) : 1014 - +
12345